Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check22 days agoChange DetectedThe website has been updated with new additions including the latest revision v2.11.0, while previous notices and older revisions up to v2.10.5 have been removed.SummaryDifference1%
- Check30 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.8%
- Check44 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated with new entries including a revision to v2.10.2 and an addition related to the European Medicines Agency, while the previous revision v2.10.0 has been removed.SummaryDifference0.9%
- Check87 days agoChange DetectedThe study has expanded to 65 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.3%
Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.